Tuesday, 17. May 2016

Magic-mushroom drug lifts depression in first human trial


A hallucinogenic drug derived from magic mushrooms could be useful in treating depression, the first safety study of this approach has concluded. Researchers from Imperial College London gave 12 people psilocybin, the active component in magic mushrooms. All had been clinically depressed for a significant amount of time — on average 17.8 years. None of the patients had responded to standard medications, such as selective serotonin re-uptake inhibitors (SSRIs), or had electroconvulsive therapy.

nature.com

Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study pdf

... Link (0 comments) ... Comment